Palbociclib Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Palbociclib Capsule (capsule) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Apr 22, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Pfizer Inc.
- Package NDC
- 0069-0187-21
- Dosage Form
- Capsule
- Presentation
- Ibrance, Capsule, 75 mg (NDC 0069-0187-21)
- Initial Posting
- Apr 22, 2026